Christopher Sampson
Can competition improve management quality in the NHS?
No Responses »
Chris Sampson reports on a discussion paper produced by the Centre for Economic Performance, which looks at the impact of competition on management quality in hospitals.
[read the full story...]Away from crime and into treatment: diversion and aftercare for drug-using offenders
Can we steer drug-using offenders away from crime and into treatment? Chris Sampson explores a study of the cost-effectiveness of diversion and aftercare programmes for offenders using class A drugs.
[read the full story...]Searching for the cost of bipolar disorder
Bipolar disorder is associated with high economic costs…or is it? Chris Sampson reports on a new systematic review, which highlights limitations in our understanding.
[read the full story...]Do perinatal mental health problems cost the UK £8 billion per year?
A recent report estimated the societal cost of perinatal mental health problems to be £8 billion, but should we believe it? Chris Sampson advises caution.
[read the full story...]Are treatments for borderline personality disorder cost-effective?
Our resident Elf Economist, Chris Sampson, reports on a new systematic review of economic evaluations for borderline personality disorder. Are any cost-effective?
[read the full story...]Are treatments for bipolar disorder cost-effective?
Chris Sampson reports on a recent systematic review and critical appraisal of economic evaluations in bipolar disorder. He finds that there’s a pressing need for new studies, especially discrete event simulations.
[read the full story...]Cytisine and varenicline for smoking cessation
Andrew Jones and Chris Sampson report on a systematic review and economic evaluation of cytisine and varenicline for smoking cessation, which finds that both drugs are clinically effective compared with placebo.
[read the full story...]CBT in primary care is cost-effective for treatment-resistant depression
Elf economist Chris Sampson reports on the economic evaluation of the CoBalT RCT, which finds that CBT is cost-effective for treatment resistant depression in primary care.
[read the full story...]Joint crisis plans: cost-effective for whom?
Chris Sampson looks at the economic outcomes of a recent RCT of joint crisis plans to reduce compulsory treatment for people with psychosis. The study reports the potential for gains specifically among Black patients.
[read the full story...]Health effects of depression: keeping economists’ models on track
Health Economist Christopher Sampson reports on a recent systematic review and meta-analysis, which shows health-related quality of life utility values vary between studies and economic models should consider this.
[read the full story...]